Search Results
Results found for "Joshua Gross"
Posts (42)
- Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics" Ross
- Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes
Self-docking and cross-docking simulations of G protein-coupled receptor-ligand complexes: Impact of of 11 Class A GPCR crystallized in multiple activation states (giving rise to 37 self-docking and 68 cross Our results show that one specific subset of cross-docking simulations gave results of similar quality RMSD values for top-scored poses were 1.2 Ã… and 2.0 Ã… for self-docking and StateMatch/FunctionMatch cross-docking
- 📰 GPCR Weekly News, June 10 to 16, 2024
GPCR Priming: The Hidden Synergy in Cellular Signalling Alberto Gonzalez-Hernandez, Hermany Munguba, Joshua
Other Pages (23)
- Dr. Alix A. J. Rouault | Dr. GPCR Ecosystem
Joshua Gross were enthusiastic about the idea and jumped on board. Dylan Eiger , and Joshua Gross. We are very excited about this event.
- Dr. Ross Cheloha | Dr. GPCR Ecosystem
Ross Cheloha About this episode Dr. Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Ross and I chatted about his work and transition to an independent investigator; join me to learn more Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr.
- YC-Blog (List) | Dr. GPCR Ecosystem
Let’s talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution
